Search for Clinical Trial Results
Hemangiosarcoma - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Doxorubicin With Upfront Dexrazoxane Plus Olaratumab for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma Condition:
|
Recruiting |
Study Name: Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue Sarcoma Condition:
Interventions: |
Completed |
Study Name: Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic Sarcoma Condition:
Interventions: |
Completed |
Study Name: Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma Condition:
Interventions: Drug: romidepsin DEP is administered at a dose of 13 mg/m2 as a 4-hour intravenous infusion in the outpa |
Active, not recruiting |
Study Name: Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma Condition:
Interventions: |